Journal rankings · indicator year 2023
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2023
Pharmaceutical Science journal rankings 2023
43 ranked journals · Subfield in Pharmacology, Toxicology and Pharmaceutics
Pharmaceutical Science has 43 ranked journals in 2023. The median OJR fell 0.06 on 2022 to 0.63, below the world average of 1.00; Q1 starts at OJR 1.10. The top three are Drug Delivery, Drug Delivery and Translational Research, and Expert Opinion on Drug Delivery.
Ranks and citation indicators: 2023. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2020–2022, the window the 2023 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Pharmacology, Toxicology and Pharmaceutics (4)
43 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2022. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2020–2022, the window the 2023 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2020–2022 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2014 to 2023. | Compare |
|---|---|---|---|---|---|---|---|
1Drug DeliveryOATaylor & Francis · United Kingdom | 1.97Q1 | 7.15 0.60 up from 2022 | 647 | 100% | $2,864 | ||
2Drug Delivery and Translational ResearchSpringer Science+Business Media · United States | 1.78Q1 | 6.51 0.13 up from 2022 | 565 | 45% | $4,690 | ||
3Expert Opinion on Drug DeliveryTaylor & Francis · United Kingdom | 1.75Q1 | 5.48 1.59 down from 2022 | 336 | 40% | — | ||
4International Journal of PharmaceuticsElsevier BV · Netherlands | 1.57Q1 | 5.95 0.39 down from 2022 | 3,092 | 39% | $4,650 | ||
5Future Journal of Pharmaceutical SciencesOASpringer Science+Business Media · Egypt | 1.50Q1 | 4.98 1.03 up from 2022 | 430 | 100% | $0 listed | ||
6Journal of Pharmaceutical InvestigationSpringer Science+Business Media · South Korea | 1.49Q1 | 6.02 0.17 down from 2022 | 141 | 10% | $3,890 | ||
7International Journal of Pharmaceutics XOAElsevier BV · Netherlands | 1.45Q1 | 5.86 1.43 up from 2022 | 103 | 100% | $2,590 | ||
8European Journal of Pharmaceutical SciencesOAElsevier BV · Netherlands | 1.38Q1 | 4.95no change | 920 | 100% | $3,070 | ||
9European Journal of Pharmaceutics and BiopharmaceuticsElsevier BV · Netherlands | 1.34Q1 | 4.93 0.44 down from 2022 | 721 | 40% | $4,210 | ||
10Journal of Drug Delivery Science and TechnologyElsevier BV · France | 1.29Q1 | 4.89 0.28 down from 2022 | 2,372 | 19% | $3,810 | ||
11AAPS PharmSciTechSpringer Science+Business Media · United States | 1.10Q1 | 4.05 0.13 up from 2022 | 862 | 29% | $4,190 | ||
12Pharmaceutical ResearchSpringer Science+Business Media · United States | 1.07Q2 | 4.01 0.32 up from 2022 | 679 | 41% | $4,690 | ||
13Journal of MicroencapsulationTaylor & Francis · United Kingdom | 0.98Q2 | 3.46 0.61 down from 2022 | 135 | 8% | — | ||
14Drug Development and Industrial PharmacyTaylor & Francis · United States | 0.89Q2 | 2.63 0.87 down from 2022 | 443 | 11% | — | ||
15AAPS OpenOASpringer Nature · Germany | 0.88Q2 | 2.77 1.85 up from 2022 | 32 | 100% | $2,090 | ||
16ADMET & DMPKOAInternational Association of Physical Chemists (IAPC) · Croatia | 0.85Q2 | 3.81 1.27 up from 2022 | 68 | 100% | — | ||
17Scientia PharmaceuticaOAÖsterreichische Apotheker-Verlagsgesellschaft m. b. H. · Switzerland | 0.84Q2 | 2.93 0.47 down from 2022 | 181 | 100% | $1,207 | ||
18Pharmaceutical Development and TechnologyTaylor & Francis · United States | 0.78Q2 | 2.69 0.56 down from 2022 | 286 | 14% | — | ||
19Therapeutic DeliveryFuture Science Ltd · United Kingdom | 0.74Q2 | 1.97 1.55 down from 2022 | 169 | 20% | — | ||
20Journal of Pharmaceutical InnovationSpringer Science+Business Media · United Kingdom | 0.70Q2 | 2.23 0.60 down from 2022 | 257 | 20% | $3,990 | ||
21Critical Reviews in Therapeutic Drug Carrier SystemsBegell House · United States | 0.69Q2 | 2.95 0.17 up from 2022 | 62 | 8% | — | ||
22Current Drug DeliveryBentham Science Publishers · Netherlands | 0.63Q2 | 2.39 0.03 down from 2022 | 428 | 5% | — | ||
23Turkish Journal of Pharmaceutical SciencesOAGalenos Yayinevi · Türkiye | 0.62Q3 | 1.81 0.30 up from 2022 | 329 | 100% | — | ||
24Assay and Drug Development TechnologiesMary Ann Liebert, Inc. · United States | 0.56Q3 | 1.78 0.25 down from 2022 | 114 | 10% | — | ||
25Pharmaceutical NanotechnologyBentham Science Publishers · Netherlands | 0.50Q3 | 2.00 0.54 up from 2022 | 111 | 9% | — | ||
26Recent Patents on NanotechnologyBentham Science Publishers · Netherlands | 0.49Q3 | 2.07 0.01 down from 2022 | 121 | 5% | — | ||
27Recent Advances in Drug Delivery and FormulationNetherlands | 0.47Q3 | 1.45 0.01 down from 2022 | 38 | 3% | — | ||
28Brazilian Journal of Pharmaceutical SciencesOAUniversity of São Paulo · Brazil | 0.42Q3 | 0.86 0.77 down from 2022 | 639 | 100% | — | ||
29Journal of Fluorine ChemistryElsevier BV · Netherlands | 0.41Q3 | 1.54 0.18 down from 2022 | 406 | 16% | $3,660 | ||
30Indian Journal of Pharmaceutical Education and ResearchAssociation of Pharmaceutical Teachers of India · India | 0.37Q3 | 1.17 0.12 down from 2022 | 623 | 100% | — | ||
31Journal of Drug Delivery and TherapeuticsOASociety of Pharmaceutical Tecnocrats · India | 0.30Q3 | 0.90 0.11 down from 2022 | 1,302 | 100% | — | ||
32Asian Journal of Pharmaceutical Research and DevelopmentOASociety of Pharmaceutical Tecnocrats · India | 0.29Q3 | 0.85 0.21 up from 2022 | 221 | 100% | — | ||
33Dissolution TechnologiesUnited States | 0.27Q3 | 0.88 0.16 up from 2022 | 81 | 84% | — | ||
34Drug Delivery LettersBentham Science Publishers · Netherlands | 0.25Q4 | 0.67 0.31 down from 2022 | 79 | 12% | — | ||
35International Journal of Pharmacy and Pharmaceutical SciencesOAInnovare Academic Sciences · India | 0.21Q4 | 0.71 0.07 up from 2022 | 375 | 100% | — | ||
36Current NanomedicineNetherlands | 0.20Q4 | 0.80 0.12 down from 2022 | 54 | 0% | — | ||
37Journal of Drug DeliveryHindawi Publishing Corporation · United Kingdom | 0.13Q4 | 0.49 0.15 down from 2022 | 39 | — | — | ||
| 0.13Q4 | 0.41no change | 39 | 100% | — | |||
39Current Drug TherapyBentham Science Publishers · Netherlands | 0.11Q4 | 0.38 0.19 down from 2022 | 104 | 6% | — | ||
| 0.10Q4 | 0.29 0.01 down from 2022 | 34 | — | — | |||
41American Journal of Advanced Drug DeliveryOAUnited States | 0.09Q4 | 0.00 0.52 down from 2022 | 40 | — | — | ||
42British Journal of PharmacyOAUniversity of Huddersfield Press · United Kingdom | 0.06Q4 | 0.24 0.47 down from 2022 | 72 | 100% | — | ||
| 0.06Q4 | 0.13 0.19 down from 2022 | 82 | 100% | — |
Subfields of Pharmacology, Toxicology and Pharmaceutics, with Pharmaceutical Science highlighted.
Journals
Citations made in 2023. Corpus-wide, 88.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
8 additional Pharmaceutical Science journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2020–2022, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2023. Publication window: 2020–2022. How these summaries are calculated
- Ranked journals
- 43
- Window papers (baseline)
- 20,406 +14.0% from indicator year 2020
- Median OJR
- 0.63 -3.9% from indicator year 2020
- Rising journals (2025)
- 4
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2020–2022 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 13 | 16 | 16 | 16 | 16 | 18 | 19 | 20 | 20 | 22 | 23 | 27 | 31 | 36 | 41 | 43 | 44 | 43 | 43 | 45 | 41 | 42 | 42 | 43 | 42 | 43 | |
| Window papers (baseline) | 7,475 | 7,588 | 7,654 | 8,087 | 8,285 | 8,674 | 8,975 | 9,518 | 10,113 | 10,822 | 11,808 | 12,971 | 14,267 | 15,539 | 16,907 | 17,880 | 18,737 | 18,998 | 18,769 | 18,134 | 17,898 | 18,805 | 19,869 | 20,406 | 20,468 | 20,952 | |
| Median OJR | 0.620 | 0.6911 | 0.623 | 0.85 | 0.826 | 0.77 | 0.81 | 0.89 | 0.82 | 0.91 | 0.828 | 0.880 | 0.879 | 0.72 | 0.6908 | 0.657 | 0.54 | 0.57 | 0.65 | 0.53 | 0.655 | 0.64 | 0.70 | 0.63 | 0.61 | 0.68 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.